|
[1]
|
Ashhab, A.A., Rodin, H., Campos, M., et al. (2020) Response to Hepatitis B Virus Vaccination in Individuals with Chronic Hepatitis C Virus Infection. PLoS ONE, 15, e0237398. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
刘步平, 孙锋, 林亮, 等. CNKI中前列腺炎高被引文献的计量分析[J]. 中华男科学杂志, 2014, 20(10): 943-948.
|
|
[3]
|
王凤英, 曹松, 于德军, 王淑艳, 徐志峰. 检测慢性乙肝及乙肝肝硬化患者血小板功能的意义[J]. 临床肝胆病杂志, 2002(3): 175-176.
|
|
[4]
|
王晓晗. 益气解毒通络方治疗乙肝肝硬化有效性及其控制癌变的研究[J]. 智慧健康, 2020, 6(17): 154-155.
|
|
[5]
|
World Health Organization (2017) Global Hepatitis Report 2017. World Health Organization.
https://apps.who.int/iris/handle/10665/255016
|
|
[6]
|
Guan, X., Xing, F. and Li, Y. (2020) Alcohol Consumption Increases the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B Cirrhosis But Not in Patients with Hepatitis C Cirrhosis. European Journal of Gastroenterology & Hepatology, 10, 1097. [Google Scholar] [CrossRef]
|
|
[7]
|
黄拼搏, 胡志刚, 许侨东, 颜永聪, 王捷. ALPPS在具有乙肝肝硬化背景的巨块型肝癌中的应用[J]. 岭南现代临床外科, 2015, 15(5): 527-532.
|
|
[8]
|
赵蔚, 张英. HBeAg阴性和阳性乙肝肝硬化患者血常规, 肝功能, HBVDNA, Child-Pugh分级对比分析[J]. 山西医科大学学报, 2014, 45(8): 736-739.
|
|
[9]
|
常桂彬, 郑玉宝. 乙肝肝硬化患者抑郁情绪与肝硬化病情严重程度的相关性[J]. 热带医学杂志, 2014, 14(7): 871-873+896.
|
|
[10]
|
周小军, 孟晓军, 林子玲, 宋家武, 边壮, 郭惠学. 疏肝健脾法联合拉米夫定治疗乙肝肝硬化的临床疗效观察[J]. 中药材, 2011, 34(10): 1639-1641.
|
|
[11]
|
杨宏志, 李春涛, 王拥泽, 关卫兵, 杨跃武. 清下消补法组方对乙肝肝硬化预后因素影响的临床观察[J]. 中药材, 2003(11): 841-843.
|
|
[12]
|
Zhang, T., Yang, Y., Wang, B., et al. (2019) Meta-Analysis of Influences of Biejiajian Pill Combined with Entecavir on Serum Liver Fibrosis Markers of Compensatory Period of Hepatitis B Cirrhosis: Protocol of Systematic Review and Meta-Analysis. Medicine, 98, e18458. [Google Scholar] [CrossRef]
|